In North Korea’s first comments directed at the Biden administration, Kim Jong Un’s powerful sister on Tuesday warned the United States to “refrain from causing a stink” if it wants to “sleep in peace” for the next four years.
In North Korea’s first comments directed at the Biden administration, Kim Jong Un’s powerful sister on Tuesday warned the United States to “refrain from causing a stink” if it wants to “sleep in peace” for the next four years.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. GOFORE PLC STOCK EXCHANGE RELEASE 23 APRIL 2021 AT 12:25 EET A total of 1,000,000 new shares in Gofore Plc registered with the Trade Register On 22 April 2021, Gofore Plc (“Gofore” or the “Company”) announced the result of the directed share issue of 1,000,000 new shares in an accelerated bookbuilding to eligible Finnish and international institutional and other qualified investors (the “Placing”). In the Placing, the Company issued a total of 1,000,000 new shares. The new shares have today been registered with the Trade Register maintained by the Finnish Patent and Registration Office. Following the registration of the new shares, the total number of registered shares in the Company is 15,052,231. The new shares will confer the same shareholder rights as the existing shares in the Company. The new shares are expected to be ready for delivery to the investors against payment through Euroclear Finland Ltd on or about 26 April 2021. Trading in the new shares (ISIN code FI4000283130) is expected to commence on the official list of Nasdaq Helsinki Ltd on or about 27 April 2021. For further information: Mikael Nylund, CEO, Gofore Plc tel. +358 40 540 2280 firstname.lastname@example.org Gofore Plc is a digital transformation consultancy with close to 800 impact-driven employees across Finland, Germany, Spain, and Estonia – top experts in our industry who are our company’s heart, brain, and hands. We use our holistic service offering – consulting, coding, design and assurance – as tools to incite positive change. We care for our people, our customers, and the surrounding world. Our values guide our business: Gofore is a great workplace that thrives on customer success. In 2020, our net sales amounted to EUR 78 million. Gofore Plc’s share is listed on the Nasdaq Helsinki Ltd. in Finland. Get to know us better at www.gofore.com. Forward-looking statements This stock exchange release includes forward-looking statements which are not historical facts but statements regarding future expectations instead. These forward-looking statements include without limitation, those regarding the expected date for delivery of the new shares and the date on which trading in the new shares is expected to commence on the official list of Nasdaq Helsinki Ltd. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance and are based on numerous assumptions. Important notice The distribution of this release may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restrictions. The information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia, the “United States”), Canada, New Zealand, Australia, Japan, Hong Kong, Singapore, South Africa or any other jurisdiction in which the distribution or release would be unlawful. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This release is not directed to, and is not intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. This release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Canada, New Zealand, Australia, Japan, Hong Kong, Singapore, South Africa or any other jurisdiction in which such offers or sales are unlawful (the “Excluded Territories”). Any failure to comply with this may constitute a violation of the securities laws of the relevant Excluded Territory or the securities laws of other states, as the case may be. The securities referred to in this release have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or under the securities laws of any state of the United States, and may not be offered, sold, resold or delivered, directly or indirectly, in or into the United States absent registration except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act. Subject to certain limited exceptions, the securities referred to in this release are being offered and sold only outside the United States. The securities issued in connection with the offering have not been and will not be registered under any applicable securities laws of any state, province, territory, county or jurisdiction of the Excluded Territories. Accordingly, such securities may not be offered, sold, resold, taken up, exercised, renounced, transferred, delivered or distributed, directly or indirectly, in or into the Excluded Territories or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration of such securities in, the relevant jurisdiction. There will be no public offer of securities in the United States or elsewhere. This release is not a prospectus as defined in the Regulation (EU) 2017/1129 (the “Prospectus Regulation”) or in the United Kingdom, Regulation (EU) 2017/1129, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the “UK Prospectus Regulation”), and has been prepared on the basis that any offers of securities referred to herein in any member state of the European Economic Area or the United Kingdom will be made pursuant to an exemption under the Prospectus Regulation or the UK Prospectus Regulation, as applicable, from any obligation to prepare a prospectus and as such, this release does not constitute or form part of and should not be construed as, an offer to sell, or the solicitation or invitation of any offer to buy, acquire or subscribe for, any securities or an inducement to enter into investment activity. The information set forth in this release is only being distributed to, and directed at, persons in member states of the European Economic Area and the United Kingdom who are qualified investors within the meaning of the Prospectus Regulation or the UK Prospectus Regulation, as applicable (“Qualified Investors”). In addition, this information is only being communicated to, and is only directed at, persons outside the United Kingdom or, in the United Kingdom, to Qualified Investors (i) having professional experience in matters relating to investments who are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”), (ii) high net worth entities falling within Article 49(2)(a)–(d) of the Order, or (iii) persons to whom it may otherwise lawfully be communicated (“Relevant Persons”). This information must not be acted or relied on by, and any investment activity to which this information relates is not available to and may not be engaged with, persons (i) in any member state of the European Economic Area who are not Qualified Investors, and (ii) in the United Kingdom who are not Relevant Persons. Any securities mentioned herein are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, Relevant Persons. Danske Bank acts only for and on behalf of Gofore in connection with the share issue. Danske Bank does not hold any other party as its client and is not responsible for providing advice to any other party than Gofore in relation to the share issue or any other matters referred to herein.
Summary Melanoma of the skin is a serious and aggressive form of cancer originating from melanocytes, the pigment cells in skin, and can develop anywhere on the body.New York, April 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Melanoma - Global Drug Forecast and Market Analysis to 2029" - https://www.reportlinker.com/p06066604/?utm_source=GNW Although melanoma has high survivability, it remains a significant health risk around the world. Where possible, melanoma is treated with surgery, with stage III patients likely to receive adjuvant therapy with either PD-1 inhibitors; BMS’ Opdivo or Merck & Co’s Keytruda or, if BRAF V600-positive, Novartis’ BRAF/MEK inhibitor combination Tafinlar + Mekinist.Metastatic melanoma is treated with systemic therapy with either PD-1 monotherapy (Opdivo or Keytruda) or BMS’ combination therapy of Opdivo + CTLA-4 inhibitor Yervoy. BRAF V600-positive patients also have the option of receiving targeted therapy. The global market is expected to grow from $5.6B in 2019 to $7.46B in 2029 at a CAGR of 2.9%. The introduction of 12 new pipeline agents as well as label expansions of currently approved agents are key drivers of this market growth. However, multiple patent expiries of market-leading brands, occurring across the 8MM, will prohibit growth. Key Highlights - The main drivers of growth include the anticipated approval and launch of 12 pipeline therapies, in addition to label expansions of currently marketed therapies across the 8MM during the forecast period. - The main barriers to growth in the 8MM are key patent expiries of immune checkpoint inhibitors and targeted BRAF/MEK inhibitors - Among the late-stage pipeline products and marketed agents, immune checkpoint inhibitors are expected to generate the greatest revenues over the forecast period. - The most important unmet needs in the melanoma market include: wider therapeutic options for patients who progress on immune checkpoint inhibitors, effective treatment for patients with brain metastases, biomarkers to guide treatment decisions, and wider options for patients with acquired resistance to targeted therapy. KEY QUESTIONS ANSWERED - 12 late-stage pipeline agents are expected to enter the melanoma market from 2021 onwards. What impact will these agents have on the market? Which of these drugs will have the highest peak sales, and why? - What are the current unmet needs melanoma, which pipeline agents are positioned to counter these unmet needs? What are the opportunities for R&D? - What is the market outlook in the 8MM from 2019-2029? Considering major patent expiries, launch of new premium priced agents and expected label expansions. - What are the main corporate trends? Who are the current and future players? Scope - Overview of melanoma including epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines. - Topline melanoma market revenue, annual cost of therapy, and major pipeline product sales in the forecast period. - Key topics covered include current treatment and pipeline therapies, unmet needs and opportunities, and the drivers and barriers affecting melanoma therapeutics sales in the 8MM. - Pipeline analysis: Comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs (Phase II - III). - Analysis of the current and future market competition in the global melanoma therapeutics market. Insightful review of the key industry drivers and challenges. Each trend is independently researched to provide qualitative analysis of its implications. Reasons to Buy The report will enable you to - - Develop and design your in-licensing and out-licensing strategies, using a detailed overview of current pipeline products and technologies to identify companies with the most robust pipelines. - Develop business strategies by understanding the trends shaping and driving the global melanoma therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global melanoma market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Track drug sales in the global melanoma therapeutics market from 2019-2029. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.Read the full report: https://www.reportlinker.com/p06066604/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The "Halal Cosmetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Facilities Management - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Facilities Management -Amid the COVID-19 crisis, the global market for Facilities Management estimated at US$1.4 Trillion in the year 2020, is projected to reach a revised size of US$3 Trillion by 2027, growing at a CAGR of 11.3% over the analysis period 2020-2027. Commercial, one of the segments analyzed in the report, is projected to record a 12.5% CAGR and reach US$1.6 Trillion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Government segment is readjusted to a revised 10.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $417.7 Billion, While China is Forecast to Grow at 10.8% CAGRThe Facilities Management market in the U.S. is estimated at US$417.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$522.6 Billion by the year 2027 trailing a CAGR of 10.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.1% and 9.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.Residential Segment to Record 9% CAGRIn the global Residential segment, USA, Canada, Japan, China and Europe will drive the 8.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$212.1 Billion in the year 2020 will reach a projected size of US$385.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$351 Billion by the year 2027. Key Topics Covered: I. METHODOLOGYII. EXECUTIVE SUMMARY1. MARKET OVERVIEW Influencer Market InsightsWorld Market TrajectoriesFacilities Management - Supporting Core Activities of BusinessesRecent Market ActivityChanging Work Culture in Modern Businesses Enhances Need for Efficient Facilities ManagementFacilities Management Market Positioned for STable GrowthNotable Trends in the Global FM Market - In a NutshellDemand for FM Services Continues to Grow at a Strong RateDeveloped Regions Lead, Emerging Economies Spearhead Future GrowthPositive Global Economy Buoys General Market OptimismRecovery in Construction Activity Worldwide Offer Bright Prospects for FM MarketImpact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS ABM Industries Incorporated (USA)Amey Plc (UK)Aramark Corporation (USA)Bellrock Limited (UK)Bilfinger Europa (UK)Bouygues Energies & Services (UK)CBRE Group, Inc. (USA)Compass Group Plc (UK)Cushman & Wakefield (USA)Elior UK (UK)EMCOR Group, Inc. (USA)ENGIE Services, Inc. (Canada)Etisalat Facilities Management L.L.C (UAE)Fluor Corporation (USA)Globe Williams International (Australia)Interserve Plc (UK)ISS UK (UK)ISS A/S (Denmark)Kier Group plc (UK)MITIE plc (UK)Sodexo S.A. (France)Turner Facilities Management Ltd. (UK)VINCI Facilities (UK) 3. MARKET TRENDS & DRIVERS Cost Reduction - The Prime DriverEfficiency Enhancements - The Road to SuccessChanging Workplace Conditions Influence FM MarketFacility Managers Focus on Specifically Designed Office Spaces As Remote Learning/Working Becomes the NormIFM Services Spurs Demand for Multi-Service ProvidersReal Estate Sector and Residential Sectors to Benefit from Facility Management ServicesVenturing into New Verticals - A Competitive StrategyTechnology Makes In-Roads into FM SpaceTechnology to Continue Playing a Prominent Role in Outsourced FM ServicesCloud Computing to Drive Adoption of FM SoftwareAutomation and Data Analysis - Vital for Next Generation FM MarketIoT - Rising Prominence in Improving Efficiency of FM ServicesBig Data & Analytics - Enabling Smart Decision Making ProcessTechnology Trends Driving Innovation in Facilities ManagementRising Significance of Technology in Retail Facilities ManagementTechnological Sustainability - An Important Trend in FM MarketIncreasing Reliance on AutomationData Security Gains ImportanceWorkforce Integration and Total FM (TFM) ContractsSustainable Building Practices Spur GrowthContract Cleaning: A Stable & Growing MarketCommercial Sector Leads Contract Cleaning Services MarketCatering Services Market - Outsourcing Gains ProminenceHealthcare Facilities Management Market - Promising Growth in StoreRegulatory Compliance Needs Present Opportunities for FM Service ProvidersChallenges in StoreMigration to FM: Not So Easy As it Seems!Facility Managers Themselves Pose a RiskManaging the Built Environment: Companies Doing It the Wrong Way!Market Maturity 4. GLOBAL MARKET PERSPECTIVE III. MARKET ANALYSIS IV. COMPETITION Total Companies Profiled: 101 For more information about this report visit https://www.researchandmarkets.com/r/lk4jj CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Everything you need to know ahead of the game
Everything you need to know ahead of the game
Summary Lung cancer remains a leading cause of cancer-related death worldwide and is a huge global health burden. Small cell lung cancer constitutes approximately 10-15% of all lung cancers and is a subtype characterized by aggressive disease and a lack of therapeutic options, resulting in poor clinical outcomes for patients.New York, April 23, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Small Cell Lung Cancer - Opportunity Analysis and Forecasts to 2029" - https://www.reportlinker.com/p06066615/?utm_source=GNW The approval and introduction of immune checkpoint inhibitors in combination with chemotherapy in the ES-SCLC setting has finally introduced a novel therapeutic approach in an indication dominated by the use of generic chemotherapy for decades.Despite a marginal (but significant) improvement in clinical outcomes for patients, the introduction of IO represents a welcome change in the treatment paradigm. Other catalysts of significance include the market withdrawal of Opdivo and Keytruda from the indication and the recent introduction of Zepzelca and Cosela into the treatment paradigm. Despite the introduction of new market entrants, significant opportunity exists across several patient subsets and multiple lines of therapy for R&D. the analyst anticipates 10 pipeline agents to be launched across the 8MM (the majority in China) over the forecast period 2019-2029. The SCLC market is forecast to grow to $2.4B by 2029, at a Compound Annual Growth Rate (CAGR) of 12.9%. This report covers opportunities for various marketed agents and pipeline agents in development across the 8MM, clinical and commercial assessments for agents in late-stage clinical development, R&D strategies, and innovative approaches in development for SCLC. This edition provides an update to the previous sales forecast for marketed and pipeline agents and highlights expected market dynamics by country and class of therapy across the forecast period, 2019-2029. Key Highlights - The main drivers of growth include the anticipated approval and launch of 10 pipeline therapies (the majority being launched in China) and greater market access across the 8MM for premium priced agents - The main barriers to growth in the 8MM include an absence of predictive biomarkers leading to a lack of targeted approaches in the treatment paradigm - A Shift in the treatment paradigm from the use of inexpensive generic chemotherapies to a mixture of chemotherapy/IO, which are associated with higher costs - The most important unmet needs in the SCLC market include: Limited understanding of underlying SCLC biology, a lack of effective treatments as a result, especially in the relapsed / refractory setting KEY QUESTIONS ANSWERED - 10 late-stage pipeline agents are going to enter the SCLC market from 2019 onwards. Will the impact will these agents have on the market? Which of these drugs will have the highest peak sales, and why? - What are the current unmet needs in SCLC, which pipeline agents are positioned to counter these unmet needs? What are the opportunities for R&D? - What is the market outlook in the 8MM from 2019-2029? Considering major patent expiries, launch of new premium priced agents and expected label expansions. - What are the main corporate trends? Who are the current and future players? Scope - Overview of SCLC including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines. - Topline SCLC market revenue, annual cost of therapy, and major pipeline product sales in the forecast period. - Key topics covered include current treatment and pipeline therapies, unmet needs and opportunities, and the drivers and barriers affecting SCLC therapeutics sales in the 8MM. - Pipeline analysis: Comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs (Phase III). - Analysis of the current and future market competition in the global SCLC market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications. Reasons to Buy The report will enable you to - - Develop and design your in-licensing and out-licensing strategies, using a detailed overview of current pipeline products and technologies to identify companies with the most robust pipelines. - Develop business strategies by understanding the trends shaping and driving the global SCLC therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global SCLC market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Track drug sales in the global SCLC therapeutics market from 2019-2029. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.Read the full report: https://www.reportlinker.com/p06066615/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The two fishermen were knocked off rocks at Kurnell but only one of them survived.
Industry insider say government likely to reveal traffic light lists on 6 or 7 May
Here's the latest for Friday April 23rd: Biden looks for help with climate agenda; Daunte Wright funeral in Minneapolis; Protests in North Carolina after law enforcement shooting kills man; House votes to make Washington, DC 51st state.
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Mezcal Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, Product, and Sales Channel" report has been added to ResearchAndMarkets.com's offering. According to this report the global mezcal market was valued at US$ 727.11 million in 2019 and is projected to reach US$ 1,136.55 million by 2027; it is expected to grow at a CAGR of 6.1% from 2020 to 2027. The report highlights key factors driving the market growth and prominent players along with their developments in the market.Mezcal beverage is made from the agave plant (traditionally, it is known as maguey). The big difference between the Mezcal and Tequila is the way agaves are cooked to extract all the fermentable sugars. Agaves or magueys are mostly found in many parts of Mexico and south to the Equator, though most mezcal is made in Oaxaca. Mezcal can be prepared from many different varieties of agave. Agave Espadin is the most popular variety, and it is produced in specific states as well. Mexico has nearly 330,000 hectares cultivating agave for Mezcal, owned by different producers. The title of a person responsible for preparing mezcal is "Maestro Mezcalero," and more often than not, their trade has been passed on from generation to generation. Types of mescal such as Mezcal Joven, Mezcal Reposado, Mezcal Anejo, and Others are quite popular among consumers in Mexico and in other countries. Growing preference for luxurious alcoholic beverages among consumers is propelling the market growth for mescal.Based on product, the mezcal market is segmented into Mezcal Joven, Mezcal Reposado, Mezcal Anejo, and Others. In 2019, the Mezcal Joven segment dominated the market by accounting for 55.4% of the total share. Unaged mezcal is basically referred to as Joven, or as young. Joven is the more preferred drink, followed by Reposado as it has similar flavor like tequila. Mezcal Joven is cheaper than other types as it can be consumed at the age of less than two months or un-aged. It is available in different flavors such as citrus, green apple, and white pepper. Mezcal Joven is mostly preferred in cocktails to add the sacred flavor of sweet agave in the drinks. The heart of Joven is mainly produced at a traditional Palenque in Matatlan, but it is grown and distilled in Oaxaca (region of Mexico). The delicate and sparkling nose of wood smoke and savory herbs introduces citrus, bright, tart fruit, and peppery palate in the drink. Mezcal Joven receives high demand among consumers worldwide due to its more distinct and crisper taste than other mezcal varieties.El Silencio, Mezcal Vago, Pernod Ricard, Ilegal Mezcal, Rey Campero, Mezcal Amores, Craft Distillers, Los Danzantes, Mezcalgulroo, and Wahaka are among the well-established players in the global Mezcal market.Impact of COVID-19 Pandemic on Mezcal MarketThe COVID-19 outbreak was first reported in Wuhan (China) during December 2019. As of January 2021, the US, Brazil, India, Russia, Spain, and the UK are among the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 pandemic is adversely affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The food and beverage is one of the world's major industries suffering serious disruptions such as supply chain breaks, technology events cancellations, and office shutdowns. For instance, China is the global manufacturing hub and largest raw material supplier for various industries and it is also one of the worst affected countries. The lockdown of various plants and factories in China is hindering the global supply chains and disrupting the manufacturing activities, delivery schedules, and various materials sales. Numerous companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition, the global travel bans imposed by countries in Europe, Asia, and North America are hampering the business collaborations and partnerships opportunities. All these factors are anticipated to hinder the food & beverages industry, which would restrain the growth of various markets related to this industry in the coming months.Reasons to Buy Highlights key business priorities to assist companies realign their business strategies.Features key findings and crucial progressive industry trends in the global mezcal market, thereby allowing players to develop effective long-term strategies.Develops/modifies business expansion plans by using substantial growth offering from developed and emerging markets.Scrutinizes in-depth market trends as well as key market drivers and restraints.Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals. Key Topics Covered: 1. Introduction1.1 Study Scope1.2 Research Report Guidance1.3 Market Segmentation2. Key Takeaways3. Research Methodology3.1 Scope of the Study3.2 Research Methodology3.2.1 Data Collection:3.2.2 Primary Interviews:3.2.3 Hypothesis formulation:3.2.4 Macro-economic factor analysis:3.2.5 Developing base number:3.2.6 Data Triangulation:3.2.7 Country level data:4. Mezcal Market Landscape4.1 Market Overview4.2 PEST Analysis4.2.1 North America4.2.2 Europe4.2.3 APAC4.2.4 MEA4.2.5 SAM4.3 Expert Opinion5. Mezcal Market - Key Market Dynamics5.1 Market Drivers5.1.1 Increasing Demand for Luxury and Premium Beverages5.1.2 E-commerce to Become Convenient Way for Shopping Alcoholic Beverages5.2 Restraint5.2.1 Stringent Regulations Related to Alcoholic Drinks5.3 Opportunity5.3.1 Increasing Demand for Craft Spirits5.4 Future Trend5.4.1 Increasing Demand of Mezcal to Experience Consolidation5.5 Impact Analysis6. Mezcal - Global Market Analysis6.1 Mezcal Market Overview6.2 Mezcal Market -Revenue and Forecast to 2027 (US$ Million)6.3 Market Positioning - Global Market Players7. Mezcal Market Analysis - By Type7.1 Overview7.2 Mezcal Market, By Type (2019 and 2027)7.3% Agave7.3.1 Overview7.3.2% Agave: Mezcal Market - Revenue, and Forecast to 2027 (US$ Million)7.4 Blends7.4.1 Overview7.4.2 Blends: Mezcal Market - Revenue, and Forecast to 2027 (US$ Million)8. Mezcal Market Analysis - By Product8.1 Overview8.2 Mezcal Market, By Product (2019 and 2027)8.3 Mezcal Joven8.3.1 Overview8.3.2 Mezcal Joven: Mezcal Market - Revenue, and Forecast to 2027 (US$ Million)8.4 Mezcal Reposado8.4.1 Overview8.4.2 Mezcal Reposado: Mezcal Market - Revenue, and Forecast to 2027 (US$ Million)8.5 Mezcal Anejo8.5.1 Overview8.5.2 Mezcal Anejo: Mezcal Market - Revenue, and Forecast to 2027 (US$ Million)8.6 Others8.6.1 Overview8.6.2 Others: Mezcal Market - Revenue, and Forecast to 2027 (US$ Million)9. Mezcal Market Analysis - By Sales Channel9.1 Overview9.2 Mezcal Market, By Sales Channel (2019 and 2027)9.3 HORECA9.3.1 Overview9.3.2 HORECA: Mezcal Market - Revenue, and Forecast to 2027 (US$ Million)9.4 Specialty Stores9.4.1 Overview9.4.2 Specialty Stores: Mezcal Market - Revenue, and Forecast to 2027 (US$ Million)9.5 Hypermarkets and Supermarkets9.5.1 Overview9.5.2 Hypermarkets and Supermarkets: Mezcal Market - Revenue, and Forecast to 2027 (US$ Million)9.6 Online9.6.1 Overview9.6.2 Online: Mezcal Market - Revenue, and Forecast to 2027 (US$ Million)10. Mezcal Market Analysis - Geographic Analysis10.1 Overview10.2 North America: Mezcal Market10.3 Europe: Mezcal Market10.4 APAC: Mezcal Market10.5 Middle East and Africa: Mezcal Market10.6 South America: Mezcal Market11. Impact of COVID-19 Pandemic on Global Mezcal Market11.1 Overview11.2 North America: Impact Assessment of COVID-19 Pandemic11.3 Europe: Impact assessment of COVID-19 Pandemic11.4 Asia-Pacific: Impact assessment of COVID-19 Pandemic11.5 Middle East and Africa: Impact assessment of COVID-19 Pandemic11.6 South America: Impact assessment of COVID-19 Pandemic12. Company Profiles12.1 EL SILENCIO HOLDINGS, INC.12.1.1 Key Facts12.1.2 Business Description12.1.3 Products and Services12.1.4 Financial Overview12.1.5 SWOT Analysis12.2 MEZCAL VAGO12.2.1 Key Facts12.2.2 Business Description12.2.3 Products and Services12.2.4 Financial Overview12.2.5 SWOT Analysis12.3 PERNOD RICARD12.3.1 Key Facts12.3.2 Business Description12.3.3 Products and Services12.3.4 Financial Overview12.3.5 SWOT Analysis12.4 Ilegal Mezcal12.4.1 Key Facts12.4.2 Business Description12.4.3 Products and Services12.4.4 Financial Overview12.4.5 SWOT Analysis12.5 Rey Campero12.5.1 Key Facts12.5.2 Business Description12.5.3 Products and Services12.5.4 Financial Overview12.5.5 SWOT Analysis12.6 Mezcal Amores12.6.1 Key Facts12.6.2 Business Description12.6.3 Products and Services12.6.4 Financial Overview12.6.5 SWOT Analysis12.7 Craft Distillers12.7.1 Key Facts12.7.2 Business Description12.7.3 Products and Services12.7.4 Financial Overview12.7.5 SWOT Analysis12.8 Los Danzantes12.8.1 Key Facts12.8.2 Business Description12.8.3 Products and Services12.8.4 Financial Overview12.8.5 SWOT Analysis12.9 Mezcalgulroo12.9.1 Key Facts12.9.2 Business Description12.9.3 Products and Services12.9.4 Financial Overview12.9.5 SWOT Analysis12.10 Wahaka12.10.1 Key Facts12.10.2 Business Description12.10.3 Products and Services12.10.4 Financial Overview12.10.5 SWOT Analysis13. Appendix13.1 About the Publisher13.2 Glossary of TermsFor more information about this report visit https://www.researchandmarkets.com/r/q696tv CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The "Wastewater Treatment Services - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeBally's Corporation(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure22/04/2021(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”YES / NO / N/AIf YES, specify which: Offeree: Gamesys Group plc 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security:USD 0.01 common InterestsShort positionsNumber%Number%(1) Relevant securities owned and/or controlled: 525,449 1.2376 (2) Cash-settled derivatives: - 0 (3) Stock-settled derivatives (including options) and agreements to purchase/sell: - 0 TOTAL: 525,449 1.2376 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant securityPurchase/saleNumber of securitiesPrice per unitUSD 0.01 commonSale61557.80USD 0.01 commonSale96757.80USD 0.01 commonSale1,30757.80USD 0.01 commonSale4,35857.80USD 0.01 commonSale34757.80USD 0.01 commonPurchase45,77757.80USD 0.01 commonSale35,63457.80 (b) Cash-settled derivative transactions Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unitUSD 0.01 commonCFDReducing a long position2,54957.80 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit (ii) Exercise Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none” (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none” (c) Attachments Is a Supplemental Form 8 (Open Positions) attached?YES/NO Date of disclosure:23/04/2021Contact name:Abdi MusseTelephone number:+442071443164 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.
Find the best leaky gut supplements in 2021 and review top leaky gut syndrome product formulas with potent ingredient benefits and no negative side effects.Chicago, IL, April 23, 2021 (GLOBE NEWSWIRE) -- Chronic inflammation in the gut is becoming an increasingly common problem for adults. It’s often referred to as having a “leaky gut” or “leaky gut syndrome.” When untreated it can cause severe bloating, gas, cramps, food sensitivities, and severe pain. This is made more difficult by the fact there is no true medical diagnosis for leaky gut. It is very much a grey area in the medical world and we still do not know much about this condition. Thankfully, there is a growing amount of evidence that supplementation may be able to reduce this inflammation and stop the adverse effects of leaky gut syndrome. We’ve compiled a list of the best supplements for leaky gut syndrome. If you’re someone suffering from chronic digestive issues, then a leaky gut product may be right for you. Here are best leaky gut supplements for 2021 and beyond: Ranking the Top Leaky Gut Syndrome Support Supplements in 2021#1 – Leaky Gut Revive® Leaky Gut Revive® is our #1 rated leaky gut supplement for its’ scientifically developed blend of ingredients known to improve digestive health. Developed by Amy Myers, a well renowned functional medicine physician, Leaky Gut Revive® was designed eliminate gut inflammation and to improve gut permeability to stop leaky gut in its’ tracks. Leaky Gut Revive has everything you’d want in a supplement for leaky gut. It contains glutamine to help restore gut lining by synthesizing protein for cell reproduction. DGL (a special kind of licorice) helps create a healthy intestinal barrier while marshmallow root provides a protective layer over the lining of the intestines. If you truly believe you are suffering from leaky gut, then your first choice absolutely should be Leaky Gut Revive. There are thousands of happy customers around the globe, the formula is backed by science, and its’ backed by one of the most respected doctors in the globe. Leaky Gut Revive is a no brainer. #2– Gundry MD Total Reserve Gundry MD Total Reserve is a true leaky gut supplement designed specifically to strengthen your gut lining. Minerals and amino acids like magnesium, glutamine, and glucosamine increase cell replication in the gut and provide an additional layer of protection on the stomach lining. Other anti-inflammatory compounds like cinnamon, licorice, grape seed, and grapefruit help to suppress the inflammation responsible for stomach pain, bloating, gas, and other digestive issues. We could go on and on about Total Reserve, but as far as we are concerned, it’s one of the best leaky gut supplements. Total Reserve has proven ingredients to support digestive health. It’s manufactured by Gundry MD, one of the leaders in the supplement space, and it’s one of the most well reviewed leaky gut supplements online. Total Reserve is a complete leaky gut supplement and an excellent overall product. #3 – Peak BioBoost Peak BioBoost isn’t a traditional leaky gut supplement but instead focuses specifically on regulating your body’s biome through prebiotics. Prebiotics are fibrous compounds that good bacteria in your gut feed on. This process regulates your gut flora and helps prevent gas, bloating, diarrhea, and many other digestive issues. Most leaky gut supplements contain prebiotics with a few other compounds to eliminate leaky gut so we are a bit disappointed Peak BioBoost doesn’t have a few other additional ingredients in it. Still, prebiotics are proven to improve digestive health and to reduce leaky gut related inflammation and therefore Peak BioBoost may be best suited for those suffering from extreme gut inflammation. #4 – Viscera-3 SANE Viscera-3 labels itself a “post-biotic” supplement meant to improve the health of the entire digestive tract – all the way from the stomach to the colon. In reality, Vicera-3 is a dual combo prebiotic and probiotic supplement designed to “cleanse” the digestive tract, reduce gut inflammation, and to support colon health. Vicera-3 is manufactured right here in the United States in an FDA-approved facility and comes with the longest money back guarantee we could find – a full one-year money back guarantee. It’s also tested for purity and potency to guarantee freshness. Overall, there’s a lot to like about Viscera-3 and it’s a solid product. #5 – BioTrust Gut Reg BioTrust Gut Reg helps strengthen the lining of your intestine using a patented ingredient called PepZin GI®. PepZin GI is actually a patented complex of zinc and L-carnosine and its’ digestive benefits are backed by almost twenty clinical studies. In addition to PepZin, Gut Reg also contains glutamine, which is known to support the walls of digestive organs as well as ginger, a powerful immune system boosting root. Together, these four ingredients work to stop leaky gut quickly and to strengthen your immune system. There are few leaky gut supplements that use clinically proven ingredients like Gut Reg, which is why it’s considered one of the best. Plus, you can order Gut Reg for as under $20 per bottle, which is why it arguably provides you with the best value – especially compared to other products that cost as much as $70 per month. #6 – Gundry MD Bio Complete 3 Bio Complete 3 is another digestive health supplement from GundryMD. Unlike Total Reserve, Bio Complete 3 is a basic formula consisting of prebiotic, probiotic, and post-biotic ingredients. Prebiotics are meant to fuel the good bacteria in your gut. Probiotics supply the gut with over 10 billion live CFUs, or colony forming units (live bacteria). Postbiotics help to provide a protective layer on the lining in your gut to prevent leaky gut. Bio Complete 3’s unique approach to leaky gut is why it deserves to make it on the top list. It may even be best used with Total Reserve for complete digestive support however it certainly has enough punch to stop leaky gut in its’ tracks. #7 – 1MD GutMD 1MD is one of the most respected supplement companies in the industry and their leaky gut supplement is one of the best. Known as 1MD GutMD, this supplement is made specifically to repair the lining in the gut. GutMD uses three patented ingredients along with glutamine to repair the epithelial tissue in the intestinal wall. GutGuard®, a patented form of licorice helps protect the lining of your GI tract from bad bacteria while HMO Care4U® actively work to reduce the number of bad bacteria in your system. Overall, GutMD is one of the few leaky gut supplements backed by clinically studied ingredients. If you need a stronger, proven product, GutMD is the perfect product to eliminate your leaky gut. #8 – Unify Health Labs Multi-GI 5 Multi G1-5 takes a three-pronged approach to eliminating leaky gut with prebiotics, probiotics, and a “GI health” blend. Combined, this potent formula strengthens the lining in your digestive tract, eliminates inflammation in the gut, and enhances nutrient absorption. The only thing really holding Multi GI-5 back is its’ price. It’s a little on the pricier side compared to other leaky gut supplements. Still one of the better supplements for leaky gut and is one of the best reviewed. Therefore, it’s worthy of consideration for leaky gut. #9 – ActivatedYou Morning Complete ActivatedYou Morning Complete is a daily wellness drink packed with prebiotics, probiotics, and leafy green superfoods. Truthfully, Morning Complete is less of a leaky gut supplement and more of a total digestive supplement. Prebiotics and probiotics support a healthy biome, which in turn reduces the inflammation responsible for your symptoms. Some of the fruit and superfood greens do help with cellular function so it is entirely possible that Morning Complete can help eliminate leaky gut. However, we feel Morning complete is more of a supplement for digestive health than specifically for leaky gut. How We Ranked Since leaky gut isn’t an actual medical condition, there’s no clinical research to evaluate what supplements are effective and which supplements are not effective in treating a leaky gut. Therefore, we had to adjust how we evaluated our top leaky gut supplements by considering a number of factors like: Ingredient formula: The ingredient formula is important because there’s no clinical research on leaky gut syndrome. We gave high marks to products that contained ingredients like probiotics & collagen because they have been clinically proven to support gut health or strengthen connective tissues and organs in the body. We also looked for products with strong anti-inflammatory ingredients like licorice root, marshmallow, and turmeric because inflammation in the gut is likely the cause of indigestion, diarrhea, and many of the other symptoms of leaky gut syndrome. Customer reviews: Since no clinical studies have been conducted on leaky gut supplements, we had to dig deep and read through thousands of customer reviews to determine the best products. We looked at product rating, # of ratings, average rating among users, and whether users ultimately felt better after taking leaky gut supplements. At the end of the day, the customer knows best whether a product is doing anything for them. Therefore, we strongly considered customer reviews when evaluating our top leaky gut supplements. Price/Value: Leaky gut supplements are often more expensive than other categories of supplements and some companies charge upwards of $75 for just a one-month’s supply. While it’s true that you get what you pay for in the supplement industry, we felt like some products were priced too high. What we tried to do was find the products that are the likeliest to deliver results but also provide maximum value. As a result, our top products combination of quality ingredients and competitive pricing so you get the most bang for your buck and still likely see results. Get the #1 Best Ranked Leaky Gut Supplement for Real Gut Health Benefits and Results in 2021 Today Who Needs a Leaky Gut Supplement? Truthfully, there’s a lot we don’t know about leaky gut. It’s a very broad term that could be the result of any number of things. We do know that intestinal permeability is likely the main cause for leaky gut syndrome, although even the most knowledgeable experts suggest that this is only likely a small part of a much bigger problem. When healthy, your small intestine has a strong lining that handles nutrient absorption and filters out bad pathogens. When the lining of your intestine weakens, these pathogens are able to “leak” into your body, which can cause several health problems. Since leaky gut syndrome isn’t an actual medical condition, it’s tougher to say who can benefit from taking leaky gut supplements the most. Realistically, anybody who is suffering from digestive issues, such as gas, bloating, pain, cramps, fatigue, diarrhea, or headaches may want to consider taking a leaky gut supplement. If you’re commonly having digestive issues, then there’s a good chance you may have a leaky gut. Leaky guy supplements may help to build up your intestinal permeability and improve your gut biome to improve your gut health. (HUGE SAVINGS TODAY) Save Big on the #1 Top Ranked Leaky Gut Supplement for Stomach Health Support Benefits of Leaky Gut Supplements Your gut health is essential to the overall health of your body. Research suggests that your gut health is one of the most important factors to your health – if not the most important factor. Therefore, it’s only natural to see a major improvement in various aspects of your health by fixing gut issues. This is why leaky gut supplements can have so many benefits. Leaky gut supplements improve digestive health and eliminate most digestive problems. The most prevalent symptoms of leaky gut syndrome are digestive related – with bloating, gas, and diarrhea the most common. Taking leaky gut supplements help to relieve many of these symptoms by improving your gut biome through the inclusion of prebiotics and probiotics. Probiotics add billions of healthy bacteria to your gut flora, which manage digestion and eliminate the bad bacteria that may be causing your symptoms. Additionally, leaky gut supplements strengthen the lining of your GI tract to stop leaky gut in its’ tracks. These supplements directly address your root cause of digestive issues so you’ll likely notice relief from these symptoms first before anything else. Leaky gut supplements can support healthy immune system function: The immune system is a complex network of cells, tissues, and organs that protect your body from infection and disease. Much of your immune system is reliant on a healthy GI tract. Since leaky gut syndrome causes inflammation in your gut, your body’s gut flora is thrown out of balance. Your immune system suffers as a result and you may be more susceptible to sickness, infections, or disease. Leaky gut supplements reverse the inflammation in your GI tract and help to strengthen the lining of the intestines. This stops the “leak” causing your issues and through the use of probiotics, leaky gut supplements can stabilize your gut flora to improve immunity. Leaky gut supplements may improve mood & reduce stress: There’s some evidence that leaky gut supplements may reduce stress levels and improve mood. Inflammation caused by leaky gut may interfere with the production of certain hormone levels like testosterone and estrogen. This may increase stress levels, cause anxiety, and cause mood problems. Reducing the inflammation in the gut may help your body restore hormone levels back to healthier levels, reducing the leaky gut induced stress and anxiety. Mood may also improve after healing a leaky gut as well. (LOWEST PRICE ONLINE) Get the Best Leaky Gut Supplement Directly from the Official Website for the Biggest Discount Side Effects of Leaky Gut Supplements Leaky gut supplements may contain a number of individual ingredients and therefore it’s virtually impossible to say whether every leaky gut supplement is safe. In general, leaky gut supplements are considered generally recognized as safe. For example, collagen is the fundamental building block of our bones, joints, tendons, and connective tissues in the body. It is found in virtually every leaky gut supplement because it helps strengthen the lining in the GI tract. There are no known side effects of taking collagen and it is considered one of the safest supplements you can take. Prebiotics and probiotics are also commonly added to leaky gut supplements. Prebiotics have no known side effects but probiotics may cause some minor digestive issues you likely already have digestive issues and therefore might not know any change. In general, leaky gut supplements are tolerated well and do not cause any major side effects. If you’re unsure whether a product is right for you, you should contact your doctor or a medical professional. Otherwise, you should make sure you research each ingredient in a specific product before you buy it to make sure you are not putting yourself in harm’s way. If for whatever reason you do feel like your product isn’t helping you or is causing an adverse reaction, simply discontinue use and speak to your doctor about your issues. Recommended Dosage Because leaky gut supplements may have so many ingredients, there’s no set dosage the way you would have for say, a sleep supplement or joint product. However, some popular compounds found in leaky gut products do have recommended dosages. If your leaky gut supplement contains collagen, you’ll want a dosage of around 10g of collagen per serving. If probiotics are added, you should find a product with at least 10 billion CFUs (colony forming units). As a general rule of thumb, any quality product will be formulated properly so all the ingredients can work together to optimize your gut health eliminate your leaky gut. (SPECIAL SAVINGS) Find the Most Popular Leaky Gut Health Supplement Right Now FAQQ. What exactly is leaky gut and what causes it? Leaky gut syndrome is a health condition that develops when your GI tract is unable to stop toxins from entering your blood syndrome. The exact cause of leaky gut is unknown but it is partially believed that weaker intestinal permeability is the normal cause in most adults. The small intestine contains microscopic holes that prevent unwanted particles from escaping the GI tract – things like bacteria & germs. These holes are referred to as tight junctions and when these tight junctions are unable to do their job, pathogens escape into the blood stream, causing inflammation and digestive issues. Leaky gut supplements are said to improve intestinal permeability and prevent your gut from allowing these particles to escape into your bloodstream. Q. How do I know if I have leaky gut syndrome? There is no medical definition of “leaky gut syndrome” and there’s no test available to determine if you have what is considered a leaky gut. However, according to medical experts, these are the clean signs of a leaky gut: Chronic diarrhea, constipation, gas or bloatingNutritional deficienciesPoor immune systemHeadaches, brain fog, memory lossExcessive fatigueSkin rashes and problems such as acne, eczema or rosaceaCravings for sugar or carbsArthritis or joint painDepression, anxiety, ADD, ADHDAutoimmune diseases such as rheumatoid arthritis, lupus, celiac disease or Crohn's If you have a leaky gut, then you likely have some or many of these symptoms. If so, a leaky gut supplement may correct the issues in your digestive system and eliminate many of these symptoms. Q. How can I heal my leaky gut? The cause of leaky gut syndrome isn’t fully understood. However, many experts argue that poor diet & lifestyle habits are typically the most common causes of leaky gut. Therefore, making dietary changes and lifestyle changes are the two most common recommendations to heal a leaky gut. It may be best to eliminate as much processed food from your diet as possible, cut back on alcohol consumption, reduce stress levels, and ensure you’re getting a good night’s sleep. However, for many people lifestyle and dietary changes aren’t enough, which is why leaky gut supplements are so beneficial for many people. Q. Do leaky gut supplements have any side effects? There are so many different vitamins, minerals, and herbal extracts that can go into leaky gut products. This makes it very difficult to say with 100% certainty whether leaky gut supplements are completely safe and free of side effects. In general, we’d say most leaky gut supplements are safe because they often contain ingredients like collagen, probiotics, and vitamin D, and other anti-inflammatory compounds. However, before you buy any product, it’s a good idea to research the ingredients and ensure you don’t have any potential conflicts with the ingredients. Q. What are some ingredients I should look for in a leaky gut supplement? Leaky gut supplements can contain any number of ingredients in their formula. However, there are some products that we’ve identified that are more likely to help heal your gut and prevent further inflammation. Collagen is essential to every connective tissue in the body and studies have shown it can support the structure and mucosal lining of the digestive tract. Glucosamine helps eliminate bad bacteria while also supporting the good bacteria in your GI tract. Probiotics and prebiotics help balance your microbiome and eliminate the bad bacteria causing digestive issues. Other potential beneficial compounds in leaky gut supplements include compounds like curcumin, marshmallow root, vitamin D, licorice root, digestive enzymes, caprylic acid, zinc, and berberine. Buy the Best Rated, Top Ranked, Most Popular Leaky Gut Health Supplement for Powerful Support Today Official Website: https://www.biotrust.com/ Contact Details: BioTRUST Email: email@example.com Phone: 1-800-766-5086 About MarketingByKevin.com This product review is published by Marketing By Kevin. Marketing By Kevin reviews are researched and formulated by a group of experienced natural health advocates with years of dedication and determination to finding the highest quality health products and wellness programs available. It should be noted that any purchase derived from this resource is done at your own peril. It is recommended to consult with a qualified professional healthcare practitioner before making an order today if there are any additional questions or concerns. Any order finalized from this release’s links are subject to the entire terms and conditions of the official website’s offer. The researched information above does not take any direct or indirect responsibility for its accuracy. Affiliate Disclosure: The links contained in this product review may result in a small commission to Marketing By Kevin if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team and please know we only recommend high quality products. Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely a substitute for sound medical advice from a licensed healthcare provider. Make sure to consult with a professional physician before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary as the statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. Product support: firstname.lastname@example.org Media Contact: email@example.com CONTACT: Kevin Mahoney 708-247-1324 firstname.lastname@example.org
The "Smart Coatings - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Hospitals in Delhi are suffering from crippling shortages of medical oxygen as India’s surging second wave of Covid-19 inflicts misery upon the country. Several people have died while waiting for oxygen supplies, and the bulk of intensive care beds in Delhi hospitals are occupied. Prime Minister Narendra Modi is scheduled to hold meetings on Friday with oxygen manufacturers and the chief ministers of affected states.
Trevor Phillips’ daughter Sushila and Big Brother’s Nikki Grahame have died after battles with anorexia. The pandemic has caused four times the amount of people admitted to hospital for eating disorders and specialist clinics have two-year waiting lists, so what can be done?
From anagrams to misspellings – here are all the clues and suspects for the true identity of ‘the fourth man’
The situation is said to be open after players were attacked by a group of up to 600 supporters
HMS Networks AB (publ) held its Annual General Meeting on April 23, 2021. In light of the ongoing corona pandemic and in order to minimize any risk of spreading of the corona virus, the Annual General Meeting was held only through postal voting in accordance with temporary legislation. The Meeting resolved in favour of all matters in accordance with the proposals of the Board of Directors and the Nomination Committee. The main contents of the most important resolutions are described below. Allocation of earningsThe Annual General Meeting resolved to approve the Board's proposed dividend of SEK 2.00 per share. The record date for the dividend was set to be April 27, 2021. The dividend is expected to be distributed by Euroclear Sweden on April 30, 2021. Adoption of the income statement and balance sheet and discharge from liabilityThe Annual General Meeting resolved to adopt the income statement and balance sheet for HMS Networks AB and the group as presented by the Board. The Board and the CEO were discharged from liability for the 2020 financial year. Election of Board members and auditors and determination of feesThe Annual General Meeting resolved in accordance with the Nominating Committee's proposals, namely: that six (6) Board members should be elected without any deputies,that one (1) registered public accounting firm should be elected as auditor,that the Board members Charlotte Brogren, Fredrik Hansson, Anders Mörck, Cecilia Wachtmeister, Ulf Södergren and Niklas Edling should be re-elected.that Charlotte Brogren should be re-elected as Chairman of the Board,that Öhrlings PricewaterhouseCoopers AB, with Johan Palmgren as auditor in charge, should be re-elected as auditor,that the fees to the Board members should amount to a total of SEK 1,875,000, of which SEK 625,000 should be paid to the Chairman of the Board and SEK 250,000 to each other Board member, and that fee for work in the Audit Committee should amount to SEK 100,000 to the Chairman and SEK 50,000 to each other member in the Audit Committee and that no fees should be paid for work in other committees. Board's remuneration report. The Annual General Meeting approved the Board's remuneration report. Authorisation of the Board to resolve on new share issuesThe Annual General Meeting resolved, in accordance with the Board's proposal, to authorise the Board to resolve on new share issues of maximum 2,340,943 shares in order to finance or carry out company acquisitions with the company’s own shares. Implementation of Share Saving Plan 2022-2025 and hedging activities to enable delivery of shares within the programThe Annual General Meeting resolved, in accordance with the Board's proposal, to implement a performance-based share saving plan, Share Saving Plan 2022-2025. The program is addressed to all employees and comprise a maximum of 100,000 shares. In order to enable the company’s delivery of shares to the participants in the program, the Annual General Meeting further resolved, in accordance with the Board’s proposal, to authorise the Board to repurchase a maximum of 100,000 of the company’s own shares and to transfer the repurchased shares to the participants in the program. For more information please contact: CEO Staffan Dahlström, phone: +46-35-17 29 01 CFO Joakim Nideborn, phone: +46-35-710 69 83 HMS Networks AB (publ) is a market-leading provider of solutions in industrial information and communication technology (Industrial ICT). HMS develops and manufactures products under the Anybus®, Ixxat®, Ewon® and Intesis® brands. Development takes place at the headquarter in Halmstad and also in Ravensburg, Nivelles, Igualada, Wetzlar Buchen and Delft. Local sales and support are handled by branch offices in Germany, USA, Japan, China, Singapore, Italy, France, Spain, the Netherlands, India, UK, Sweden, South Korea and UAE, as well as through a worldwide network of distributors and partners. HMS employs over 700 people and reported sales of SEK 1,467 million in 2020. HMS is listed on the NASDAQ OMX in Stockholm, category Mid Cap, Information Technology. Attachment PRM - HMS Networks Notice of AGM 2021